Terumo India introduces Insulin Syringe for patients requiring daily insulin injections to manage Diabetes bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Business at LatestLY. New Delhi [India], November 14: Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced the launch of Insulin Syringe, Sterile delivery device for patients requiring regular insulin injections, thereby raising the bar for patient comfort and therapy compliance. Business News | Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes.
New Delhi [India], September 9 (ANI/BusinessWire India): Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced the launch of FineGlide, Sterile Pen Needle for patients requiring regular insulin injections or other self-medication. Designed to be compatible with most commonly available pen devices in India, Fineglide raises the bar for patient comfort and thereby, drug compliance. Making the announcement, Managing Director of Terumo India, Shishir Agarwal said, "Patient comfort and convenience are critical attributes that have significant impact on their adherence to therapy. We are delighted to introduce FineGlide to patients and healthcare providers in India as it raises the bar for patient comfort." It is estimated that close to 78 million patients in India are having Diabetes, of these about 12 per cent patients require insulin daily to manage the disease and also there are other therapies wherein self-inject